Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...

Exporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

The most expensive pharmaceuticals include Zolgensma, Zokinvy, Danyelza, Luxturna, Ravicti, Myalept, and more.

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, explores ways that digital health platforms can assist pharma companies seeking to maintain accessibility ...